Monday, August 1, 2022

Targeted inhibition of osteoclastogenesis reveals the pathogenesis and therapeutics of bone loss under sympathetic neurostress

alexandrossfakianakis shared this article with you from Inoreader

41368_2022_193_Fig1_HTML.png

International Journal of Oral Science, Published online: 01 August 2022; doi:10.1038/s41368-022-00193-1

Targeted inhibition of osteoclastogenesis reveals the pathogenesis and therapeutics of bone loss under sympathetic neurostress
View on Web

No comments:

Post a Comment

Collaboration request

Hi there How would you like to earn a 35% commission for each sale for life by selling SEO services Every website owner requires the ...